文献速递产科母胎医学

妊娠早期子痫前期筛查:母体血流动力学与生物电阻抗在非肥胖患者中的作用

Screening for pre-eclampsia in the first trimester: role of maternal hemodynamics and bioimpedance in non-obese patients.
PubMed 文献 · Ultrasound Obstet Gynecol · 2017-01-01

研究纳入150例健康初产非肥胖孕妇,在孕早期联合筛查时行USCOM血流动力学检测、生物电阻抗分析及子痫前期联合筛查,随访至足月。12例(8%)发生子痫前期和/或胎儿生长受限,病例组心输出量、肌力指数及总体水低于对照组,总血管阻力更高,联合筛查阳性率更高;肌力指数、脂肪量及联合筛查为独立预测因子。

要点

  • 非肥胖初产孕妇孕早期病例组心输出量5.6±0.3 vs 对照组6.7±1.1 L/min,P<0.001。
  • 病例组总血管阻力1279.8±166.4 vs 对照组1061.4±179.5 dynes×s/cm5,P<0.001。
  • 联合筛查阳性率病例组50% vs 对照组8%,P<0.001。

核心结论

  • 子痫前期联合筛查结合生物电阻抗和母体血流动力学评估可用于识别心血管适应不良和体成分改变的早期标志物,这些改变可能导致妊娠晚期并发症。

研究设计与样本

  • 纳入150例孕早期健康初产非肥胖女性(体重指数<30 kg/m2),行USCOM血流动力学检测、生物电阻抗分析及子痫前期联合筛查,随访至足月记录子痫前期和/或胎儿生长受限的发生。

主要发现

  • 138例妊娠无异常(对照组),12例(8%)发生并发症(病例组)。
  • 病例组较对照组心输出量降低(5.6±0.3 vs 6.7±1.1 L/min,P<0.001),肌力指数降低(1.54±0.38 vs 1.91±0.32 W/m2,P<0.001),总血管阻力升高(1279.8±166.4 vs 1061.4±179.5 dynes×s/cm5,P<0.001)。
  • 病例组较对照组总体水降低(53.7±3.3% vs 57.2±5.6%,P=0.037)。
  • 联合筛查子痫前期阳性率病例组50% vs 对照组8%(P<0.001)。
  • 前向多因素logistic回归分析确定肌力指数(USCOM衍生)、脂肪量(生物电阻抗分析衍生)和联合筛查为妊娠并发症的独立预测因子。

关键数值与推荐

  • 原文报告了USCOM和生物电阻抗参数的截断值,但摘要未给出具体数值。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To test if maternal hemodynamics and bioimpedance, assessed at the time of combined screening for PE, are able to identify in the first trimester of gestation normotensive non-obese patients at risk for pre-eclampsia (PE) and/or intrauterine growth restriction (IUGR). METHODS: One hundred and fifty healthy nulliparous non-obese women (body mass index < 30 kg/m2 ) in the first trimester of pregnancy underwent assessment by UltraSonic Cardiac Output Monitor (USCOM) to detect hemodynamic parameters, bioimpedance analysis to characterize body composition, and combined screening for PE (assessment of maternal history, biophysical and maternal biochemical markers). Patients were followed until term, noting the appearance of PE and/or IUGR. RESULTS: One hundred and thirty-eight patients had an uneventful pregnancy (controls), while 12 (8%) developed complications (cases). USCOM showed, in cases compared with controls, lower cardiac output (5.6 ± 0.3 vs 6.7 ± 1.1 L/min, P < 0.001), lower inotropy index (1.54 ± 0.38 vs 1.91 ± 0.32 W/m2 , P < 0.001) and higher total vascular resistance (1279.8 ± 166.4 vs 1061.4 ± 179.5 dynes × s/cm5 , P < 0.001). Bioimpedance analysis showed, in cases compared with controls, lower total body water (53.7 ± 3.3% vs 57.2 ± 5.6%, P = 0.037). Combined screening was positive for PE in 8% of the controls and in 50% of the cases (P < 0.001). After identification of cut-off values for USCOM and bioimpedance parameters, forward multivariate logistic regression analysis identified as independent predictors of complications in pregnancy the inotropy index (derived by USCOM), fat mass (derived from bioimpedance analysis) and combined screening. CONCLUSIONS: Combined screening for PE and assessment of bioimpedance and maternal hemodynamics can be used to identify early markers of impaired cardiovascular adaptation and body composition that may lead to complications in the third trimester of pregnancy. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Gagliardi G, Tiralongo GM, LoPresti D, et al. Screening for pre-eclampsia in the first trimester: role of maternal hemodynamics and bioimpedance in non-obese patients. Ultrasound Obstet Gynecol. 2017. PMID: 27925328. doi:10.1002/uog.17379

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。